EBS Emergent BioSolutions Inc. Stock Quote

EBS [NYSE]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	9.01	EPS (ttm)	7.15	Insider Own	0.90%	Shs Outstand	53.30M	Perf Week	3.14%
Market Cap	3.41B	Forward P/E	12.74	EPS next Y	5.05	Insider Trans	-16.76%	Shs Float	48.52M	Perf Month	7.23%
Income	387.30M	PEG	0.98	EPS next Q	1.54	Inst Own	85.60%	Short Float	7.38%	Perf Quarter	3.96%
Sales	1.71B	P/S	2.00	EPS this Y	445.20%	Inst Trans	-0.18%	Short Ratio	5.09	Perf Half Y	-39.89%
Book/sh	28.57	P/B	2.25	EPS next Y	-37.48%	ROA	14.30%	Target Price	91.14	Perf Year	-27.63%
Cash/sh	10.34	P/C	6.23	EPS next 5Y	9.20%	ROE	28.60%	52W Range	55.07 - 137.61	Perf YTD	-28.14%
Dividend	-	P/FCF	10.99	EPS past 5Y	24.00%	ROI	14.30%	52W High	-53.21%	Beta	0.94
Dividend %	-	Quick Ratio	2.10	Sales past 5Y	26.00%	Gross Margin	69.00%	52W Low	16.93%	ATR	2.20
Employees	2200	Current Ratio	3.20	Sales Q/Q	78.20%	Oper. Margin	31.70%	RSI (14)	55.84	Volatility	3.77% 3.35%
Optionable	Yes	Debt/Eq	0.56	EPS Q/Q	632.00%	Profit Margin	22.70%	Rel Volume	0.33	Prev Close	63.65
Shortable	Yes	LT Debt/Eq	0.55	Earnings	Jul 29 AMC	Payout	0.00%	Avg Volume	703.26K	Price	64.39
Recom	2.20	SMA20	3.63%	SMA50	5.02%	SMA200	-23.27%	Volume	234,713	Change	1.16%

May-05-21

Downgrade

Argus

Buy → Hold

Apr-07-21

Initiated

The Benchmark Company

Buy

$150

Feb-24-21

Upgrade

Chardan Capital Markets

Neutral → Buy

$112

Feb-19-21

Downgrade

Chardan Capital Markets

Buy → Neutral

$112

Jan-08-21

Downgrade

Wells Fargo

Overweight → Equal Weight

$110

Sep-14-20

Resumed

JP Morgan

Neutral

$103

Jul-31-20

Reiterated

Chardan Capital Markets

Buy

$86 → $112

Sep-12-19

Initiated

Guggenheim

Buy

Sep-04-19

Upgrade

Wells Fargo

Market Perform → Outperform

Nov-02-18

Upgrade

Goldman

Neutral → Buy

Aug-03-18

Reiterated

Chardan Capital Markets

Buy

$53 → $57

Jun-13-18

Initiated

Argus

Buy

$62

Apr-25-18

Downgrade

Wells Fargo

Outperform → Market Perform

Jan-24-18

Initiated

Goldman

Neutral

Jan-16-18

Reiterated

Chardan Capital Markets

Buy

$47 → $53

Jun-28-16

Reiterated

Singular Research

Buy

$44 → $40

Apr-15-16

Initiated

Chardan Capital Markets

Buy

$47

Mar-28-16

Initiated

Singular Research

Buy

$44

Feb-19-16

Initiated

Wells Fargo

Outperform

May-15-14

Initiated

Summer Street Research

Buy

$35

Jul-25-21 04:21AM	Emergent BioSolutions (NYSE:EBS) Shareholders Booked A 93% Gain In The Last Five Years Simply Wall St.
Jul-22-21 03:03PM	Analysts Estimate Emergent Biosolutions (EBS) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-20-21 07:25AM	EBS Long Term Investor Alert: Did You Acquire (EBS) Before April 24, 2020? - Contact Johnson Fistel Regarding Investigation GlobeNewswire
Jul-15-21 06:30AM	Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021 GlobeNewswire
Jul-07-21 09:39AM	Emergent BioSolutions Faces Lawsuits Related to Vaccine Troubles Barrons.com
Jul-03-21 08:02AM	Can Emergent BioSolutions Recover From Its Recent Blunders? Motley Fool
Jul-02-21 04:11PM	UPDATE 1-U.S. authorizes additional batch of J&J COVID-19 vaccine produced by Emergent Reuters
Jun-29-21 07:01AM	Why Johnson & Johnson Is Trashing 60 Million Doses of Its COVID Vaccine Motley Fool
Jun-24-21 09:19AM	Did You Acquire (EBS) Before April 24, 2020? Johnson Fistel Investigates Emergent; Should Management be Held Accountable for Investors Losses? GlobeNewswire
Jun-23-21 10:52AM	U.S. House panels expand probe into Emergent's Baltimore COVID-19 vaccine plant Reuters
09:06AM	Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders Newsfile
Jun-22-21 05:29AM	Promise Emerging for Emergent BioSolutions TipRanks
Jun-21-21 05:01PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - EBS Newsfile
03:30PM	Today - Final Deadline for Investors with Losses Exceeding $250K to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
02:00PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EBS, ATER and WISH ACCESSWIRE
01:20PM	MONDAY DEADLINE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:34PM	Final Deadline Today: Rosen, Global Investor Counsel, Reminds Emergent BioSolutions Inc. Investors with Losses Over $100K of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday - EBS Newsfile
09:45AM	Lawsuits Filed Against ACAD, EBS and WISH - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
09:10AM	FINAL DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:40AM	CLASS ACTION UPDATE for EBS, SKLZ and SPCE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00AM	FINAL DEADLINE MONDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-20-21 12:30PM	Final Deadline Monday: Rosen, A Top Ranked Law Firm, Reminds Emergent BioSolutions Inc. Investors with Losses Over $100K of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday - EBS Newsfile
11:35AM	CLASS ACTION UPDATE for EBS, VRUS and OCGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:10AM	SHAREHOLDER ALERT: ACAD EBS SKLZ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:42AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jun-19-21 08:27AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jun-18-21 08:20PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and FREQ ACCESSWIRE
08:02PM	UPDATED DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Reminds Emergent BioSolutions Inc. Investors With Losses Over $100K of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday - EBS PR Newswire
07:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS ACCESSWIRE
12:00PM	SHAREHOLDER ALERT: EBS ARRY PRVB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:55AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:11AM	EBS UPDATED DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Informs Emergent BioSolutions Inc. Investors of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday EBS GlobeNewswire
10:00AM	Final Deadline for Investors to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC Newsfile
Jun-17-21 07:00PM	EMERGENT BIOSOLUTIONS 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBS PR Newswire
06:40PM	EBS DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - EBS Newsfile
01:40PM	FINAL DEADLINE FRIDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:20AM	Lawsuits Filed Against EBS, PTON and FREQ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:00AM	Two Days Left to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC Business Wire
11:00AM	Tomorrow Deadline for Investors to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
10:54AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:05AM	Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Emergent BioSolutions Inc. Investors EBS Business Wire
09:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EBS, CCXI and ATER ACCESSWIRE
09:06AM	EBS INVESTOR DEADLINE TOMORROW: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors with Losses to Contact the Firm Now, Securities Fraud Lawsuit Pending GlobeNewswire
06:30AM	EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc. Newsfile
06:12AM	EBS LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of Emergent Biosolutions Inc. Shareholders Newsfile
Jun-16-21 10:26PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EBS, PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
10:26PM	EMERGENT BIOSOLUTIONS 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBS Newsfile
10:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the Firm Business Wire
06:47PM	EBS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Emergent Biosolutions Inc. Limited Shareholders Newsfile
05:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS PR Newswire
04:29PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS Newsfile
03:00PM	2-Day Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:00PM	EBS 2-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors with Losses to Contact the Firm Before June 18th Deadline ACCESSWIRE
01:10PM	Final Deadline Approaching on June 18, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Class Action Lawsuit Deadline Newsfile
12:39PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - (EBS) Newsfile
10:53AM	FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:45AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EBS, CCIV and UI ACCESSWIRE
10:00AM	Last Few Days to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLC Newsfile
05:23AM	EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc. Newsfile
Jun-15-21 11:06PM	FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of EBS, PTON, RLX and UI GlobeNewswire
06:26PM	EBS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Emergent Biosolutions Inc. Limited Shareholders Newsfile
04:51PM	3 Day Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Against Emergent BioSolutions Inc. GlobeNewswire
04:01PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS Newsfile
03:04PM	Top Pharmaceutical Stocks for Q3 2021 Investopedia
02:25PM	FINAL FRIDAY DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with LARGE LOSSES to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBS ACCESSWIRE
01:45PM	EBS, PTON, RLX, UI SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
12:44PM	Emergent BioSolutions, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit GlobeNewswire
12:00PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EBS, SKLZ and DNMR ACCESSWIRE
10:52AM	FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:35AM	EBS 3-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now Newsfile
10:00AM	Lawsuits Filed Against EBS, WISH and RLX - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
09:00AM	EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser ACCESSWIRE
05:40AM	CLASS ACTION UPDATE for EBS, PTON and PCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jun-14-21 10:56PM	SHAREHOLDER ALERT: CLAIMSFILER REMINDS EBS, PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
09:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and PRVB ACCESSWIRE
08:20PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS GlobeNewswire
06:52PM	EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc. Newsfile
05:25PM	EBS 4-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud Lawsuit ACCESSWIRE
02:51PM	EBS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 18, 2021 in the Class Action Filed on Behalf of Emergent Biosolutions Inc. Limited Shareholders Newsfile
02:41PM	Deadline Approaching for Emergent BioSolutions Investors: Berger Montague Reminds Investors of Approaching Deadline in Securities Fraud Class Action Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021 Newsfile
01:20PM	INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of EBS, PTON, RLX, UI Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
12:00PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CAN, EBS and FREQ ACCESSWIRE
11:05AM	EBS Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or June 18, 2021 Deadline in Securities Fraud Class Action Lawsuit PR Newswire
10:26AM	J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many Zacks
10:00AM	FUV, ACAD & EBS Few Days Left to Actively Participate in Class Actions: Bronstein, Gewirtz & Grossman LLC GlobeNewswire
09:35AM	LAWSUITS FILED AGAINST ACAD, EBS and SKLZ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
08:30AM	FRIDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:24AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS Newsfile
Jun-13-21 01:18PM	EBS 5-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Lawsuit Newsfile
10:15AM	CLASS ACTION UPDATE for ACAD, EBS and ATER: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jun-12-21 04:55PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS Newsfile
01:40PM	Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Deadline in Securities Fraud Class Action Lawsuit Against Emergent BioSolutions Inc. Newsfile
12:06PM	EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Action GlobeNewswire
Jun-11-21 10:00PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EBS, PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
05:25PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and DNMR ACCESSWIRE
04:35PM	COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnsons Emergency Use Authorization GlobeNewswire
02:27PM	FDA Authorizes 10M JNJ COVID-19 Vaccine Doses, Asks To Discard 60M From Emergent Plant: NYT Benzinga
01:00PM	SHAREHOLDER ALERT: ACAD EBS PCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:10PM	Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS) GlobeNewswire
12:03PM	EBS FINAL DEADLINE NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action EBS GlobeNewswire

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; and Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; and Trobigard a combination drug-device auto injector product candidate. Further, the company is developing COVID-EIG and COVID-HIG potential treatments to COVID-19 disease; and FLU-IGIV for the treatment of Influenza A infection in hospitalized patients. Additionally, it provides contract development and manufacturing service that comprises development services, drug substance manufacturing, and drug product manufacturing in the pharmaceutical and biotechnology industries, as well as the governments and non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zoon Kathryn C	Director	May 25	Sale	56.48	3,139	177,291	14,377	May 27 04:37 PM
SULLIVAN LOUIS W	Director	May 10	Option Exercise	18.64	10,305	192,085	43,063	May 11 04:18 PM
Bailey Sue	Director	Mar 04	Sale	92.37	8,168	754,478	24,427	Mar 08 06:30 PM
Havey Adam	EVP, Business Operations	Mar 01	Option Exercise	40.90	37,279	1,524,812	58,335	Mar 03 06:07 PM
Havey Adam	EVP, Business Operations	Mar 01	Sale	99.30	37,279	3,701,647	38,190	Mar 03 06:07 PM
Kramer Robert	President and CEO	Feb 08	Option Exercise	30.79	45,397	1,397,961	171,607	Feb 09 05:23 PM
Kramer Robert	President and CEO	Feb 08	Sale	120.03	45,397	5,449,002	139,210	Feb 09 05:23 PM
Kramer Robert	President and CEO	Jan 21	Option Exercise	26.45	21,900	579,255	161,110	Jan 22 04:14 PM
Kramer Robert	President and CEO	Jan 21	Sale	110.03	21,900	2,409,657	139,210	Jan 22 04:14 PM
Kramer Robert	President and CEO	Jan 20	Option Exercise	26.45	2,232	59,036	141,442	Jan 22 04:14 PM
Kramer Robert	President and CEO	Jan 20	Sale	110.00	2,232	245,520	139,210	Jan 22 04:14 PM
Kramer Robert	President and CEO	Jan 15	Option Exercise	25.62	19,026	487,446	158,236	Jan 19 04:28 PM
Kramer Robert	President and CEO	Jan 15	Sale	106.01	19,026	2,016,901	139,210	Jan 19 04:28 PM
El-Hibri Fuad	Chairman	Nov 10	Option Exercise	26.45	19,391	512,892	1,143,379	Nov 12 06:30 PM
El-Hibri Fuad	Chairman	Nov 10	Sale	88.21	19,391	1,710,480	1,123,988	Nov 12 06:30 PM
El-Hibri Fuad	Chairman	Nov 09	Option Exercise	26.45	20,000	529,000	1,143,988	Nov 12 06:30 PM
El-Hibri Fuad	Chairman	Nov 09	Sale	95.26	20,000	1,905,200	1,123,988	Nov 12 06:30 PM
El-Hibri Fuad	Chairman	Nov 03	Option Exercise	26.45	20,000	529,000	1,143,988	Nov 04 08:53 PM
El-Hibri Fuad	Chairman	Nov 03	Sale	90.74	20,000	1,814,800	1,123,988	Nov 04 08:53 PM
El-Hibri Fuad	Chairman	Nov 02	Option Exercise	26.45	20,000	529,000	1,143,988	Nov 04 08:53 PM
El-Hibri Fuad	Chairman	Nov 02	Sale	90.44	20,000	1,808,800	1,123,988	Nov 04 08:53 PM
El-Hibri Fuad	Chairman	Sep 24	Sale	98.85	12,535	1,239,085	1,123,988	Sep 25 07:00 PM
El-Hibri Fuad	Chairman	Sep 23	Sale	100.58	13,000	1,307,540	1,136,523	Sep 25 07:00 PM
El-Hibri Fuad	Chairman	Sep 17	Sale	100.68	20,000	2,013,600	1,149,523	Sep 18 06:25 PM
El-Hibri Fuad	Chairman	Sep 16	Sale	102.48	20,000	2,049,600	1,169,523	Sep 18 06:25 PM
El-Hibri Fuad	Chairman	Sep 10	Sale	102.66	20,000	2,053,200	1,189,523	Sep 11 09:21 PM
El-Hibri Fuad	Chairman	Sep 09	Sale	102.80	20,000	2,056,000	1,209,523	Sep 11 09:21 PM
SULLIVAN LOUIS W	Director	Sep 02	Option Exercise	20.08	7,893	158,491	50,655	Sep 04 08:08 PM
SULLIVAN LOUIS W	Director	Sep 02	Sale	111.22	28,418	3,160,606	42,762	Sep 04 08:08 PM
Bailey Sue	Director	Aug 18	Sale	128.31	4,665	598,564	32,595	Aug 19 05:08 PM
Harsanyi Zsolt	Director	Aug 17	Sale	133.71	6,609	883,664	24,579	Aug 18 09:12 AM
JOULWAN GEORGE A	Director	Aug 11	Sale	124.11	6,000	744,635	26,771	Aug 12 04:52 PM
Zoon Kathryn C	Director	Aug 10	Sale	130.27	1,000	130,270	12,489	Aug 11 04:43 PM
Richard Ronald	Director	Aug 07	Sale	131.00	6,297	824,907	8,276	Aug 11 04:46 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience